Showing results (211-220 of 295) with videos related to

Sort By:
Pageof 30
British Journal of Cancer|August 26, 1998
Cytotoxic therapy with etoposide and cisplatin in advanced adrenocortical carcinomaR Bonacci, A Gigliotti, E Baudin, et al.
The Journal of Clinical Endocrinology and Metabolism|August 7, 2012
Somatic RAS mutations occur in a large proportion of sporadic RET-negative medullary thyroid carcinomas and extend to a previously unidentified exonA Boichard, L Croux, A Al Ghuzlan, et al.
Annales D'Endocrinologie|January 1, 1988
[Treatment of malignant pheochromocytoma by 131-I-metaiodobenzylguanidine]B Charbonnel, J F Chatal, A J Brendel, et al.
Journal of Endocrinological Investigation|April 1, 1994
Screening for adrenal medullary disease in patients with medullary thyroid carcinomaF Bonnin, M Schlumberger, P Gardet, et al.
Presse Medicale (Paris, France : 1983)|July 27, 1999
[Neuro-endocrine tumors and von Hippel-Lindau disease. 3 cases]G Aubert-Petit, E Baudin, A F Cailleux, et al.
Medical and Pediatric Oncology|January 1, 1987
Therapeutic use of 131I-metaiodobenzylguanidine (MIBG) in neuroblastoma: a phase II study in nine patientsO Hartmann, J Lumbroso, J Lemerle, et al.
The Quarterly Journal of Nuclear Medicine : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR)|December 1, 1995
Somatostatin receptor imaging: a preliminary experience in forty-nine patientsF Giammarile, E Baudin, F Tenenbaum, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 25, 1994
Oncogenic potential of guanine nucleotide stimulatory factor alpha subunit in thyroid glands of transgenic miceF M Michiels, B Caillou, M Talbot, et al.
Pageof 30